Masaoka T - Search Results

1

Persistent oxidative stress in the corpus mucosa is evoked by long-term treatment of H. pylori-infected patients with proton pump inhibitors.

Suzuki M, Tanaka S, Suzuki K, Kitahora T, Masaoka T, Suzuki H, Hibi T. Suzuki M, et al. Among authors: masaoka t. Hepatogastroenterology. 2008 Jan-Feb;55(81):138-41. Hepatogastroenterology. 2008. PMID: 18507093

2

Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.

Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H. Ohara T, et al. Among authors: masaoka t. Hepatogastroenterology. 2004 Mar-Apr;51(56):338-42. Hepatogastroenterology. 2004. PMID: 15086153

3

Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.

Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T. Suzuki H, et al. Among authors: masaoka t. Hepatogastroenterology. 2004 Sep-Oct;51(59):1249-54. Hepatogastroenterology. 2004. PMID: 15362725

4

Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.

Masaoka T, Suzuki H, Imaeda H, Hosoda H, Ohara T, Morishita T, Ishii H, Kangawa K, Hibi T. Masaoka T, et al. Hepatogastroenterology. 2005 Jan-Feb;52(61):1-4. Hepatogastroenterology. 2005. PMID: 15782980

5

Investigation of the possibility of human-beta defensin 2 (hBD2) as a molecular marker of gastric mucosal inflammation.

Ohara T, Morishita T, Suzuki H, Masaoka T, Nishizawa T, Hibi T. Ohara T, et al. Among authors: masaoka t. Hepatogastroenterology. 2005 Sep-Oct;52(65):1320-4. Hepatogastroenterology. 2005. PMID: 16201065

6

Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.

Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T. Suzuki H, et al. Among authors: masaoka t. J Gastroenterol Hepatol. 2005 Nov;20(11):1652-60. doi: 10.1111/j.1440-1746.2005.04039.x. J Gastroenterol Hepatol. 2005. PMID: 16246181

7

Helicobacter pylori eradication restored sonic hedgehog expression in the stomach.

Nishizawa T, Suzuki H, Masaoka T, Minegishi Y, Iwasahi E, Hibi T. Nishizawa T, et al. Among authors: masaoka t. Hepatogastroenterology. 2007 Apr-May;54(75):697-700. Hepatogastroenterology. 2007. PMID: 17591044

8

Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa.

Suzuki M, Suzuki H, Masaoka T, Tanaka S, Suzuki K, Ishii H. Suzuki M, et al. Among authors: masaoka t. Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:158-64. doi: 10.1111/j.1365-2036.2004.01971.x. Aliment Pharmacol Ther. 2004. PMID: 15298622 Free article.

9

Gastric mucosal response to Helicobacter pylori.

Suzuki H, Masaoka T, Miyazawa M, Suzuki M, Miura S, Ishii H. Suzuki H, et al. Among authors: masaoka t. Keio J Med. 2002 Dec;51 Suppl 2:40-4. doi: 10.2302/kjm.51.supplement2_40. Keio J Med. 2002. PMID: 12528936 Free article. Review.

10

Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.

Suzuki H, Masaoka T, Nomura S, Hoshino Y, Kurabayashi K, Minegishi Y, Suzuki M, Ishii H. Suzuki H, et al. Among authors: masaoka t. Keio J Med. 2003 Sep;52(3):163-73. doi: 10.2302/kjm.52.163. Keio J Med. 2003. PMID: 14529149 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters